Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $889.68 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $540.03 | 30 | $0 (2020) |
| PruGen, Inc. Pharmaceuticals | $125.00 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $60.85 | 3 | $0 (2019) |
| GENZYME CORPORATION | $48.54 | 3 | $0 (2017) |
| UCB, Inc. | $18.58 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $16.98 | 1 | $0 (2019) |
| LEO Pharma Inc. | $15.76 | 1 | $0 (2017) |
| Sun Pharmaceutical Industries Inc. | $13.91 | 1 | $0 (2020) |
| Lilly USA, LLC | $13.82 | 1 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $13.53 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $98.22 | 6 | AbbVie Inc. ($70.49) |
| 2019 | $344.21 | 21 | AbbVie, Inc. ($271.91) |
| 2018 | $200.64 | 9 | AbbVie, Inc. ($173.03) |
| 2017 | $246.61 | 9 | PruGen, Inc. Pharmaceuticals ($125.00) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 03/11/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2020 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Dermatology | ||||||
| 01/22/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Immunology | ||||||
| 01/15/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Immunology | ||||||
| 11/13/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Immunology | ||||||
| 11/05/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Immunology | ||||||
| 10/22/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Immunology | ||||||
| 10/08/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Immunology | ||||||
| 10/03/2019 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/01/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Immunology | ||||||
| 09/13/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Immunology | ||||||
| 09/13/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Immunology | ||||||
| 09/03/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Immunology | ||||||
| 08/27/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Immunology | ||||||
| 08/16/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Immunology | ||||||
| 08/15/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Immunology | ||||||
| 05/23/2019 | AbbVie, Inc. | Humira (Biological), Skyrizi | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
| 05/15/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: DERMATOLOGY | ||||||
| 04/09/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Immunology | ||||||
| 03/26/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Immunology | ||||||
| 03/14/2019 | SANOFI-AVENTIS U.S. LLC | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 1,001 | 1,804 | $191,602 | $60,488 |
| 2020 | 18 | 1,881 | 3,277 | $391,762 | $131,604 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 287 | 373 | $67,041 | $20,609 | 30.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 110 | 127 | $28,343 | $10,078 | 35.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 189 | 228 | $29,636 | $7,950 | 26.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 105 | 114 | $23,327 | $6,903 | 29.6% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 30 | 34 | $11,074 | $3,922 | 35.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 151 | 765 | $9,772 | $3,801 | 38.9% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 30 | 59 | $6,131 | $2,420 | 39.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 59 | 64 | $7,068 | $2,112 | 29.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $6,401 | $1,978 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $2,809 | $714.49 | 25.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 346 | 501 | $73,109 | $24,368 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 223 | 256 | $55,149 | $20,108 | 36.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 273 | 307 | $60,447 | $19,789 | 32.7% |
| 17000 | Destruction of skin growth | Office | 2020 | 286 | 381 | $48,883 | $13,154 | 26.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 132 | 149 | $32,794 | $12,247 | 37.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 125 | 221 | $23,164 | $9,140 | 39.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 212 | 1,168 | $13,854 | $5,350 | 38.6% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2020 | 14 | 15 | $12,638 | $4,782 | 37.8% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 33 | 34 | $10,569 | $4,067 | 38.5% |
| 13101 | Repair of wound (2.6 to 7.5 centimeters) of trunk | Office | 2020 | 13 | 13 | $10,169 | $3,870 | 38.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 40 | 40 | $8,469 | $2,894 | 34.2% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 50 | 50 | $7,510 | $2,623 | 34.9% |
| 12031 | Repair of wound (2.5 centimeters or less) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 13 | 13 | $6,509 | $2,486 | 38.2% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2020 | 22 | 22 | $10,688 | $2,144 | 20.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 63 | 69 | $6,247 | $1,981 | 31.7% |
About Dr. Yebabe Mengesha, MD
Dr. Yebabe Mengesha, MD is a Dermatopathology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689687410.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yebabe Mengesha, MD has received a total of $889.68 in payments from pharmaceutical and medical device companies, with $98.22 received in 2020. These payments were reported across 45 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($889.68).
As a Medicare-enrolled provider, Mengesha has provided services to 2,882 Medicare beneficiaries, totaling 5,081 services with total Medicare billing of $192,092. Data is available for 2 years (2020–2021), covering 28 distinct procedure/service records.
Practice Information
- Specialty Dermatopathology
- Location Phoenix, AZ
- Active Since 08/14/2006
- Last Updated 10/30/2015
- Taxonomy Code 207ND0900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689687410
Products in Payments
- Humira (Biological) $458.09
- SKYRIZI (Biological) $70.49
- COSENTYX (Biological) $60.85
- DUPIXENT (Drug) $48.54
- Cimzia (Drug) $18.58
- LIBTAYO (Drug) $16.98
- ENSTILAR (Drug) $15.76
- ILUMYA (Biological) $13.91
- TALTZ (Drug) $13.82
- SIVEXTRO (Drug) $13.53
- REMICADE (Biological) $11.44
- MIRVASO (Drug) $11.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Phoenix
Dr. Toni Stockton, M.d, M.D
Dermatopathology — Payments: $30,222
Thomas Lee
Dermatopathology — Payments: $1,626
Iftikhar Ahmed, M.d, M.D
Dermatopathology — Payments: $1,427
Dr. Chen Wang, M.d, M.D
Dermatopathology — Payments: $315.56
Dr. Maria Alzona, Md, MD
Dermatopathology — Payments: $113.39
Dr. Eugene Dulaney, Md, MD
Dermatopathology